Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MD VIROLOGIST's Profile
Displaying 601-650 of 672 result(s).
CYDY CytoDyn Inc
07/21/2020 11:51:27 AM
He is not part of corporate decisio
CYDY CytoDyn Inc
07/21/2020 11:20:32 AM
I couldn't agree more. But I have q (2)
CYDY CytoDyn Inc
07/21/2020 10:47:36 AM
I have not been on in a while. But (8)
CYDY CytoDyn Inc
07/18/2020 4:51:59 PM
How cool you are a bird hunter, I h (1)
CYDY CytoDyn Inc
07/17/2020 1:39:01 PM
They also have another product alre
CYDY CytoDyn Inc
07/17/2020 1:32:50 PM
It is interesting, GSK bought the m
CYDY CytoDyn Inc
07/17/2020 12:50:18 PM
Good afternoon I thought you may be (1)
CYDY CytoDyn Inc
07/16/2020 1:14:14 PM
I don't want to beat the HIV issue (1)
CYDY CytoDyn Inc
07/16/2020 1:05:40 PM
My clinical answer comes from siste (10)
CYDY CytoDyn Inc
07/16/2020 11:13:06 AM
This may explain why the FDA is bei
CYDY CytoDyn Inc
07/16/2020 9:30:55 AM
People of Northern India not only s
CYDY CytoDyn Inc
07/15/2020 11:31:10 PM
Also Tony's boss Francis Collins, t
CYDY CytoDyn Inc
07/15/2020 11:29:47 PM
Look into the G2P project. (1)
CYDY CytoDyn Inc
07/15/2020 11:28:45 PM
There are several mechanisms of act (2)
CYDY CytoDyn Inc
07/15/2020 11:20:35 PM
Sure the restoration of a competent
CYDY CytoDyn Inc
07/15/2020 11:15:36 PM
The concentration of the receptor g
CYDY CytoDyn Inc
07/15/2020 11:08:19 PM
Agree, that is why I think Aperion (1)
CYDY CytoDyn Inc
07/15/2020 11:06:58 PM
There are multiple variations on th
CYDY CytoDyn Inc
07/15/2020 10:38:48 PM
Leronilmad blocks viral entry in HI (1)
CYDY CytoDyn Inc
07/15/2020 10:33:04 PM
Have you guys looked into BP's back
CYDY CytoDyn Inc
07/15/2020 10:23:35 PM
Yes not best study design, the idea
CYDY CytoDyn Inc
07/15/2020 4:44:49 PM
Agree
CYDY CytoDyn Inc
07/15/2020 4:44:07 PM
The standard of care is evidence ba
CYDY CytoDyn Inc
07/15/2020 4:25:30 PM
One of my favorite journals https:/
CYDY CytoDyn Inc
07/15/2020 4:23:03 PM
Not trying to be arrogant, but in t
CYDY CytoDyn Inc
07/15/2020 3:54:24 PM
I think it could be cost effective
CYDY CytoDyn Inc
07/15/2020 3:41:46 PM
This is a long report but addresses
CYDY CytoDyn Inc
07/15/2020 3:24:38 PM
From one of my HIV specialists, qui
CYDY CytoDyn Inc
07/15/2020 1:45:51 PM
In my humble opinion I think the HI (3)
CYDY CytoDyn Inc
07/13/2020 3:42:39 PM
Agreed (1)
CYDY CytoDyn Inc
07/13/2020 3:41:46 PM
He is not an orthopedic surgeon, he
CYDY CytoDyn Inc
07/13/2020 12:58:24 PM
What do think of moving Alan Timmon
CYDY CytoDyn Inc
07/13/2020 10:30:27 AM
I had a stop gap buy below 4 so it
CYDY CytoDyn Inc
07/12/2020 8:59:56 PM
Thought I should share this old Iri (2)
CYDY CytoDyn Inc
07/12/2020 8:20:57 PM
Unfortunately until autopsy it is d
CYDY CytoDyn Inc
07/12/2020 8:18:29 PM
Not many labs have CRISPR technolog
CYDY CytoDyn Inc
07/12/2020 8:15:14 PM
Very good point, the gold standard
NNLX Nanologix Inc
07/12/2020 8:10:09 PM
Agree totally.
CYDY CytoDyn Inc
07/12/2020 6:42:07 PM
Does anybody know if the majority o
CYDY CytoDyn Inc
07/12/2020 6:18:59 PM
Also I don't remember is leronilmab
CYDY CytoDyn Inc
07/12/2020 6:13:44 PM
Hey send me the link. Thanks
CYDY CytoDyn Inc
07/12/2020 6:11:17 PM
In utero or placental?
CYDY CytoDyn Inc
07/12/2020 5:24:54 PM
Also forgot to mention on 6/30 Dive
CYDY CytoDyn Inc
07/12/2020 4:39:07 PM
Hi guys I have more material inform (17)
CYDY CytoDyn Inc
07/12/2020 11:44:01 AM
Wow you obviously know your statist
CYDY CytoDyn Inc
07/12/2020 11:38:31 AM
He reported reduced viral load in t (6)
CYDY CytoDyn Inc
07/11/2020 11:00:42 PM
I forgot to mention my passion for (2)
CYDY CytoDyn Inc
07/11/2020 9:50:39 PM
I was about to leave but one of the (12)
CYDY CytoDyn Inc
07/11/2020 11:26:25 AM
Nothing against the data, but when (2)
CYDY CytoDyn Inc
07/11/2020 9:30:26 AM
Look at the authors on the manuscri (2)
Go to page:
  • << First
  • < Previous
  • 12
  • 13
  • Next >

Recent Articles

  • LEPAS L4 Launches Worldwide, Redefining Youth Travel Experience
  • OptimizeRx Shares Surge Following Impressive Q2 Earnings Report
  • Denison Mines Achieves Significant Milestones in Uranium Production
  • Richard Werner Discusses Unique Power of Banks to Create Money
  • Denison Mines Corp Shows Promising Results in Q2 Financials
  • HOTELEX 2026: A Premier Global Platform for Hospitality Trends
  • LEPAS L4 Debuts Internationally, Enriching Youth Travel Experiences
  • HOTELEX 2026 Unveils the Future of Hospitality in Shanghai
  • Top 5 Stocks Captivating Investor Attention Right Now
  • HOTELEX Shanghai 2026: A Game-Changer for Hospitality Industry
  • DAESHIN MC Introduces Innovative Solutions at BEX ASIA 2025
  • Mighty Bolton's Art of Dialogue: Journey to Global Fame
  • Celebrating 13 Years of Groundbreaking Laser Hair Removal
  • Cathie Wood’s Strategic Moves: Airbnb Gains and Selling Trends
  • DermRays Marks 13 Years of Leading Innovation in Beauty Tech
  • Driving the Future: The Expanding Automotive Smart Antenna Sector
  • O2Gold Increases Financing While Finalizing Quebec Acquisition
  • American Bitcoin's Future at NASDAQ: A Transformative Journey
  • O2Gold Progresses on Quebec Acquisition and Offers Financing Plans
  • Southwest Gas Holdings Reveals Key Pricing Details for Centuri Offering
  • Exploring the Growth of the Pressure Monitoring Market
  • FLINT Corp's Bold Move to Reshape Its Financial Future
  • Investigation into Mr. Cooper Group and Other Companies
  • BioVie Inc. Launches $12 Million Fundraising Initiative
  • FLINT Corp. Unveils Strategic Recapitalization Plan for Growth
  • Growth Forecast for Anhydrous Hydrofluoric Acid Market
  • BioVie Inc. Secures $12 Million in Innovative Offering
  • Key Insights on Potential Shareholder Benefits for AMWD, PHLT, STAA
  • Celebrating Indigenous Art: The Virtual Evolution of DAAF
  • Innovative Warehouse Solutions & Passport Partnership Fuels E-Commerce Growth
  • Critical Information for Alto Neuroscience Investors Ahead of Deadline
  • California Hotel Association Celebrates Crime Prevention Progress
  • Growth of Performance Food Group: A 5-Year Investment Story
  • Rocket Pharmaceuticals Faces Class Action for Investor Losses
  • Manulife Expands Asian Equities Team with Key Leadership Roles
  • Wi-Fi 7 Growth Opportunities and Market Insights for 2025
  • Expanding Horizons: Specialty Enzymes Market Trends 2029
  • Etoiles Capital Group Successfully Prices IPO for Growth
  • Verisk Analytics Unveils $1.5 Billion Senior Notes Offering
  • Hagerty's Class A Common Stock Offering: Details and Insights
  • A Closer Look at Rocket Lab USA's Stellar Q2 Performance
  • Maximizing Investment Returns: The Success of Cameco Corp
  • Lundin Gold Achieves Record Revenue and Strong Future Outlook
  • Join Global Investors at Costa Rica's Premier Business Summit
  • Revamping Rail Travel: Amtrak's NextGen Acela Launch Highlights
  • Engaging Global Investors: A Business Summit in Costa Rica
  • Vera Bradley, Inc. Investigates Shareholder Rights and Claims
  • Sarepta Therapeutics Investors Encouraged to Join Class Action
  • GeneDx Holdings Corp Faces Investor Claims Amid Fraud Allegations
  • Inspire Medical Systems Faces Legal Scrutiny: Investor Alert
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site